Rekdal Ø - Search Results

1

The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma.

Mauseth B, Camilio KA, Shi J, Hammarström CL, Rekdal Ø, Sveinbjørnsson B, Line PD. Mauseth B, et al. Among authors: rekdal o. Mol Ther Oncolytics. 2019 May 21;14:139-148. doi: 10.1016/j.omto.2019.05.002. eCollection 2019 Sep 27. Mol Ther Oncolytics. 2019. PMID: 31211244 Free PMC article.

2

Evidence for a direct antitumor mechanism of action of bovine lactoferricin.

Eliassen LT, Berge G, Sveinbjørnsson B, Svendsen JS, Vorland LH, Rekdal Ø. Eliassen LT, et al. Among authors: rekdal o. Anticancer Res. 2002 Sep-Oct;22(5):2703-10. Anticancer Res. 2002. PMID: 12529985

3

The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo.

Eliassen LT, Berge G, Leknessund A, Wikman M, Lindin I, Løkke C, Ponthan F, Johnsen JI, Sveinbjørnsson B, Kogner P, Flaegstad T, Rekdal Ø. Eliassen LT, et al. Among authors: rekdal o. Int J Cancer. 2006 Aug 1;119(3):493-500. doi: 10.1002/ijc.21886. Int J Cancer. 2006. PMID: 16572423

4

Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide.

Berge G, Eliassen LT, Camilio KA, Bartnes K, Sveinbjørnsson B, Rekdal O. Berge G, et al. Among authors: rekdal o. Cancer Immunol Immunother. 2010 Aug;59(8):1285-94. doi: 10.1007/s00262-010-0857-6. Epub 2010 Apr 27. Cancer Immunol Immunother. 2010. PMID: 20422410 Free PMC article.

5

Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.

Camilio KA, Berge G, Ravuri CS, Rekdal O, Sveinbjørnsson B. Camilio KA, et al. Among authors: rekdal o. Cancer Immunol Immunother. 2014 Jun;63(6):601-13. doi: 10.1007/s00262-014-1540-0. Epub 2014 Mar 28. Cancer Immunol Immunother. 2014. PMID: 24676901 Free PMC article.

6

LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent.

Camilio KA, Rekdal O, Sveinbjörnsson B. Camilio KA, et al. Among authors: rekdal o. Oncoimmunology. 2014 Jun 25;3:e29181. doi: 10.4161/onci.29181. eCollection 2014. Oncoimmunology. 2014. PMID: 25083333 Free PMC article.

7

The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.

Eike LM, Yang N, Rekdal Ø, Sveinbjørnsson B. Eike LM, et al. Among authors: rekdal o. Oncotarget. 2015 Oct 27;6(33):34910-23. doi: 10.18632/oncotarget.5308. Oncotarget. 2015. PMID: 26472184 Free PMC article.

8

The oncolytic peptide LTX-315 triggers necrotic cell death.

Forveille S, Zhou H, Sauvat A, Bezu L, Müller K, Liu P, Zitvogel L, Pierron G, Rekdal Ø, Kepp O, Kroemer G. Forveille S, et al. Among authors: rekdal o. Cell Cycle. 2015;14(21):3506-12. doi: 10.1080/15384101.2015.1093710. Cell Cycle. 2015. PMID: 26566869 Free PMC article.

9

The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma.

Eike LM, Mauseth B, Camilio KA, Rekdal Ø, Sveinbjørnsson B. Eike LM, et al. Among authors: rekdal o. PLoS One. 2016 Feb 16;11(2):e0148980. doi: 10.1371/journal.pone.0148980. eCollection 2016. PLoS One. 2016. PMID: 26881822 Free PMC article.

10

Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide.

Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø. Haug BE, et al. Among authors: rekdal o. J Med Chem. 2016 Apr 14;59(7):2918-27. doi: 10.1021/acs.jmedchem.5b02025. Epub 2016 Mar 29. J Med Chem. 2016. PMID: 26982623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters